Bis (3,5-diiodo-2,4,6-trihydroxyphenyl) squaraine photodynamic therapy induces in vivo tumor ablation by triggering cytochrome c dependent mitochondria mediated apoptosis

Photodiagnosis and Photodynamic Therapy

Volumn 10, Issue 4, 2013, Pages 510-517

  Devi, D Gayathri ^a   Cibin, T R ^a   Abraham, Annie ^a  

^a UNIVERSITY OF KERALA   (India)

Author keywords

7,12 Dimethyl benzanthracene; Apoptosis; Photodynamic therapy; Skin tumor; Squaraine dyes

Indexed keywords

7,12 DIMETHYL BENZANTHACENE; ANTINEOPLASTIC AGENT; BIS (3,5 DIIODO 2,4,6 TRIHYDROXYPHENYL) SQUARAINE; CASPASE 3; CYTOCHROME C; DYE; PHOTOSENSITIZING AGENT; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME RELEASE; FLUOROMETRY; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN TUMOR; TISSUE DISTRIBUTION; TREATMENT RESPONSE; TUMOR ABLATION; TUMOR LOCALIZATION; TUMOR VOLUME;

MUS;

7,12-DIMETHYL BENZANTHRACENE; APOPTOSIS; PHOTODYNAMIC THERAPY; SKIN TUMOR; SQUARAINE DYES;

ANIMALS; CYCLOBUTANES; CYTOCHROMES C; MALE; MICE; MITOCHONDRIA; PHENOLS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84888066837     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2013.04.005     Document Type: Article

References (31)

1. Calzavara-Pinton P.G., Arisi M., Sereni E., Ortel B. A critical reappraisal of off-label indications for topical photodynamic therapy with aminolevulinic acid and methylaminolevulinate. Reviews on Recent Clinical Trials 2010, 5:112-116.
2. Gayathri Devi D., Cibin T.R., Ramaiah D., Annie Abraham Bis (3,5-diiodo-2,4,6-trihydroxyphenyl) squaraine: a novel candidate in photodynamic therapy for skin cancer models in vivo. Journal of Photochemistry and Photobiology B: Biology 2008, 92:153-159.
3. Rekha R.A., Dhanya T.J., Adarsh N., Ramaiah D. Squaraine dyes in PDT: from basic design to in vivo demonstration. Organic and Biomolecular Chemistry 2012, 10:911-920.
4. Ramaiah D., Joy A., Chandrasekar N., Eldho N.V., Das S., George M.V. Design of halogenated squaraine dyes for photochemotherapeutical applications. Synthesis and study of photophysical and quantum yields of triplet excited states and singlet oxygen. Photochemistry and Photobiology 1997, 65:783-790.
5. Roberts W.G., Berns M.W. In vitro photosensitisation 1. Cellular uptake and subcellular localization of mono-L-aspartyl chlorine e6, chloro-aluminium sulphonated phthalocyanine and Photofrin II. Lasers in Surgery and Medicine 1989, 9:90-101.
6. Richelli F., Gobbo S., Jori G., Moreno G., Vinzens F., Salet C. Photosensitisation of mitochondria by liposome-bound porphyrins. Photochemistry and Photobiology 1993, 58:53-58.
7. Kessel D., Luo Y. Photodynamic therapy: a mitochondrial inducer of apoptosis. Cell Death and Differentiation 1999, 6:28-35.
8. Oleinick N.L., Morris R.L., Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochemical and Photobiological Sciences 2002, 1:1-21.
9. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407:770-776.
10. Ewing M.W., Conti C.J., Kruszewski F.H., Slaga T.J., DiGiovanni J. Tumor progression in sencar mouse as a function of initiator dose and promoter dose, duration and time. Cancer Research 1988, 48:7048-7054.
11. David R., Anthea M., Dipak P. Isolation and characterization of nuclei and nuclear subfractions. Subcellular fractionation: a practical approach 1997, 71-105. Oxford University Press, Oxford, England. J.M. Graham (Ed.).
12. Moan J., Peng Q., Evensen J.F., Berg K., Western A., Rimington C. Photosensitizing efficiencies, tumor and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochemistry and Photobiology 1987, 465:713-721.
13. David T., Plummer An introduction to practical biochemistry 1993, vol. 3:161-162. Tata McGraw-Hill Publishing Company Ltd., New Delhi, India.
14. Lamberg S.L., Rothstein R. Laboratory manual of histology and cytology 1978, AVI Publishing Company Inc, Westport, Connecticut, USA.
15. 2-terminal Kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Research 2000, 60:5995-6000.
16. Steel R.G.D., Torrie J.H., Dickey D.A. Principles and procedures of statistics: a biometrical approach 1997, 3:201. McGraw-Hill, New York.
17. Moan J., Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochemistry and Photobiology 1991, 53:549-553.
18. Kriska T., Korytowski W., Girotti A.W. Role of mitochondrial cardiolipin peroxidation in apoptotic photokilling of 5-aminolevulinate-treated tumor cells. Archives of Biochemistry and Biophysics 2005, 433:435-446.
19. Almeida R.D., Manadas B.J., Carvalho A.P., Duarte C.B. Intracellular signaling mechanisms in photodynamic therapy. Biochimica et Biophysica Acta 2004, 1704:59-86.
20. Sun X.M., MacFarlane M., Zhuang J., Wolf B.B., Green D.R., Cohen G.M. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. Journal of Biological Chemistry 1999, 274:5053-5060.
21. Salvesen G.S., Dixit VM Caspases: intracellular signaling by proteolysis. Cell 1997, 91:443-446.
22. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:2239-2244.
23. Hickman J.A., Potten C.S., Merritt A.J., Fisher T.C. Apoptosis and cancer chemotherapy. Philosophical Transactions of the Royal Society of London Series B: Biological Sciences 1994, 345:319-325.
24. Delehedde M., Cho S.H., Sarkiss M., Brisbay S., Davies M., El-Naggar A.K., McDonnell T.J. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer. Cancer 1999, 85:1514-1521.
25. Krajewski S., Krajewska M., Shabaik A., Wang H.G., Irie S., Reed J.C. Immunohistochemical analysis of in vivo patterns of bcl-X expression. Cancer Research 1994, 54:5501-5507.
26. Korsmeyer S.J., Shutter J.R., Veis D.J., Merry D.E., Oltvai Z.N. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Seminars in Cancer Biology 1993, 4:327-332.
27. Zaidi S.I., Oleinick N.L., Zaim M.T., Mukhtar H. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence. Photochemistry and Photobiology 1993, 58:771-776.
28. Webber J., Luo Y., Crilly R., Fromm D., Kessel D. An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo. Journal of Photochemistry and Photobiology B: Biology 1996, 35:209-211.
29. Atif M., Firdous S., Khurshid A., Noreen L., Zaidi S.S.Z., Ikram M. In vitro study of 5-aminolevulinic acid-based photodynamic therapy for apoptosis in human cervical HeLa cell line. Laser Physics Letters 2009, 6:8866-8891.
30. Mayank Srivastava, Nihal Ahmad, Sanjay Gupta, Hasan Mukhtar Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. Antisense bcl-2 oligonucleotide sensitizes rif 1 cells to photodynamic therapy apoptosis. Journal of Biological Chemistry 2001, 276:15481-15488.
31. 2 in HL60 cells. Acta Pharmacologica Sinica 2005, 26:1138-1144.